Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival.

Bone Marrow Transplant · 2026 · PMC13241302 · PMID 41991667

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significancep = 0.24not close (p > 0.1)

Median OS was numerically longer in the intermediate-risk group (1.2 years) compared with the unfavorable-risk group (0.3 years), but this difference did not reach statistical significance (log-rank p = 0.24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.